Scientific Sessions 2025  /  What A Busy Cardiologist Needs to Know About Genetics  /  Precision therapy for Genetic HCM: Cardiac Myosin Inhibitors
Logo

American Heart Association

  97
  0

Final ID:

Precision therapy for Genetic HCM: Cardiac Myosin Inhibitors

  • Kawana, Masataka  ( STANFORD UNIVERSITY , Stanford , California , United States )
  • Wilsbacher, Lisa  ( NORTHWESTERN UNIVERSITY , Evanston, IL , Illinois , United States )
  • Wheeler, Matthew  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
    • Author Disclosures:
    Masataka Kawana: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) ; Research Funding (PI or named investigator):FANCL Corp.:Active (exists now) ; Advisor:Holosis Health:Active (exists now) ; Advisor:Cardiac RSK3 Inhibitors, LLC:Active (exists now) | Lisa Wilsbacher: DO NOT have relevant financial relationships | Matthew Wheeler: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

What A Busy Cardiologist Needs to Know About Genetics

Friday, 11/07/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Should I get a polygenic risk score on my patient?

Bhattacharya Romit, Clarke Shoa, Kullo Iftikhar

Is it safe for my patient with genetic cardiomyopathy to exercise?

Lampert Rachel, Ackerman Michael, Saberi Sara, Day Sharlene

More abstracts from these authors:
Discussant: MUSIC-HFpEF

Kawana Masataka

Wrap -Up

Chahal Choudhary Anwar A., Wilsbacher Lisa

You have to be authorized to contact abstract author. Please, Login
Not Available